Funding Rounds
Dualyx

Dualyx Series A (2023, $43M)

Dualyx

Clinical-stage treatment of autoimmune and rare diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $43.44M

Investors